1. Home
  2. ATCH vs VNRX Comparison

ATCH vs VNRX Comparison

Compare ATCH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.20

Market Cap

34.9M

Sector

N/A

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.20

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
VNRX
Founded
2022
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.9M
31.9M
IPO Year
2024
2012

Fundamental Metrics

Financial Performance
Metric
ATCH
VNRX
Price
$0.20
$0.20
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$2.13
AVG Volume (30 Days)
1.4M
15.1M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
0.06
N/A
Revenue
N/A
$1,727,384.00
Revenue This Year
N/A
$479.89
Revenue Next Year
N/A
$536.25
P/E Ratio
$3.36
N/A
Revenue Growth
N/A
40.04
52 Week Low
$0.14
$0.17
52 Week High
$1.92
$0.94

Technical Indicators

Market Signals
Indicator
ATCH
VNRX
Relative Strength Index (RSI) 45.08 46.74
Support Level $0.18 $0.17
Resistance Level $0.21 $0.27
Average True Range (ATR) 0.01 0.03
MACD 0.00 0.00
Stochastic Oscillator 70.38 19.64

Price Performance

Historical Comparison
ATCH
VNRX

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: